Dr. Deena Hossino, a breast surgical oncologist at Cleveland Clinic, is highlighting new advancements and emerging technologies in breast surgery.

These innovations aim to improve patient outcomes and precision in care for a disease that affects a significant portion of the population. Because breast cancer remains a widespread health challenge, the integration of new tools allows for more personalized treatment paths.

According to data cited by StatePoint, one in eight U.S. women will be diagnosed with breast cancer during their lifetime [1]. This prevalence drives the need for the leading-edge treatments and technological innovations discussed by Hossino at the Cleveland Clinic.

Technological integration is expanding rapidly across the field. On April 29, 2026, SimBioSys announced new advancements in AI-powered surgical planning during the American Society of Breast Surgeons annual meeting [2]. These tools allow surgeons to better map procedures before entering the operating room.

Other navigation systems are also seeing global adoption. Sirius Medical announced the successful completion of the first procedures in Asia using the Pintuition surgical navigation system, according to a company press release.

Beyond high-tech navigation, the philosophy of surgical removal is evolving. Mehra Golshan said lumpectomy procedures have become more refined in combination with chemotherapy and radiation, allowing women with breast cancer to conserve more of their breasts.

These refinements in lumpectomy and the addition of AI planning represent a shift toward breast conservation. By combining surgical precision with systemic treatments, physicians can target tumors more accurately while minimizing the physical impact on the patient.

“One in eight U.S. women will be diagnosed with breast cancer during their lifetime”

The convergence of AI-powered planning, advanced navigation systems, and refined lumpectomy techniques indicates a transition toward 'precision oncology.' By reducing the amount of healthy tissue removed and using data-driven mapping, the medical community is moving away from standardized surgery toward highly individualized interventions that prioritize both cancer eradication and quality of life.